# Study for the Treatment of Anemia in Patients With Non-myeloid Malignancies Receiving Multicycle Chemotherapy.

> **NCT00148421** · PHASE3 · COMPLETED · sponsor: **Amgen**

## Conditions studied

- Anemia

## Interventions

- **DRUG:** Darbepoetin alfa and Epoetin alfa

## Key facts

- **NCT ID:** NCT00148421
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2013-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00148421

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00148421, "Study for the Treatment of Anemia in Patients With Non-myeloid Malignancies Receiving Multicycle Chemotherapy.". Retrieved via AI Analytics 2026-07-31 from https://api.ai-analytics.org/clinical/NCT00148421. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*